Translate Bio gets FDA nod for Phase 1/2 trial in OTC deficient adults

The trial is a significant milestone for the company as it advances a second mRNA therapeutic targeting a genetic disease into clinical development Translate Bio, an mRNA therapeutics company that develops transformative medicines for trea....

Krystal announces positive results from GEM-2 study of KB103

The pharmaceutical company received Regenerative Medicine Advanced Therapy designation from FDA for KB103 Krystal Biotech, Inc., a gene therapy company recently announced positive results from a Phase 2 clinical trial of KB103 (the GEM 2 s....

PHASTAR and Medidata unveil technology partnership for data services

The partnership is aimed at transforming biotech and pharmaceutical sector to safely bring new healthcare options to patients Global CRO PHASTAR and Medidata Solutions Inc. have reportedly unveiled their brand-new technology partnership. T....

Dr Reddy’s introduces medicinal equivalent of Vitamin K1 in US market

Dr. Reddy’s Laboratories Ltd., an India-based multinational pharmaceutical company, recently announced the launch of a therapeutic equivalent generic version of Phytonadione (Vitamin K1), Phytonadione Injectable Emulsion USP. The....

Wysa raises $2M in pre-series A funding round led by pi Ventures

Wysa has helped over 1.2M people across 30 countries through 80 million conversations. Wysa, an AI mental health startup based in Bengaluru, has reportedly raised $2 million (INR 15 Cr) in a pre-series A funding round led by pi Ventures. A....

DiaMedica unveils interim results from Phase 1b study of DM199 in CKD

The trial’s interim results met the expectations of the primary endpoints that include safety, tolerability and PK Clinical-stage biotech company, DiaMedica Therapeutics Inc, recently announced the interim results of Phase 1b study o....

Blue Prism advances its cloud strategy by acquiring Thoughtonomy

Blue Prism, a UK based multinational software company, recently declared to acquire UK-headquartered fast-growing technology company, Thoughtonomy. The buyout is likely to close by July 2019, claim sources. The integration of this AI techn....

Nexen Tire partners with Plug and Play for future tech development

The partnership was announced at Plug & Play’s headquarter in Sunnyvale, California Nexen Tire, a leading tire manufacturer, recently announced that it has entered into a partnership with US-based Plug & Play, an early stage ....

Celyad unveils clinical update on CYAD-01 trial for relapsed AML, MDS

Celyad, a biopharmaceutical company focused on the advancement of CAR-T cell therapies, has confirmed updated clinical data for the CYAD-01 program in r/r AML and MDS, presented through a poster presentation session on June 15, 2019 in Amst....

Thrive Global & P&G tie up on consumer behavior change via Microsteps

The New York-based Thrive Global, has reportedly signed a partnership with P&G, the American multinational consumer goods corporation to combine behavioral science and daily habits pertaining to P&G’s products to help consumer....

Our Contributors

$row3->name
Mateen Dalal
$row3->name
Akshay Kedari
« First8283848586Last »